The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This antibody has been highly used in the field by many groups to track PKA-dependent phosphorlyation status of cTnI in cardiac muscle11–15.”
From Cytoplasmic nucleic acid-based XNAs directly enhance live cardiac cell function by a Ca2+ cycling-independent mechanism via the sarcomere (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385 · cited 1×
“Several myofilament proteins are also regulated at the level of phosphorylation to affect contractile or lusitropic activity [8, 13], such as myosin light chain 2V (MLC2V) at serine 14/15 by the myosin light chain kinase (MLCK) [14, 15].”
BackgroundPhosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function
Rosas, P. C., Liu, Y., Abdalla, M. I., Thomas, C. M., Kidwell, D. T., Dusio, G. F., Mukhopadhyay, D., Kumar, R., Baker, K. M., Mitchell, B. M., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001550 · Cited by 112
Research works printed but not linked: 53
- Ceulemans, 2004, Functional diversity of protein phosphatase-1, a cellular economizer and reset button, Physiol. Rev., 84, 1, 10.1152/physrev.00013.2003 · DOI · Paper page
- Le, 2011, Identification of AKAP79 as a protein phosphatase 1 catalytic binding protein, Biochemistry, 50, 5279, 10.1021/bi200089z · DOI
- Bollen, 2010, The extended PP1 toolkit: designed to create specificity, Trends Biochem. Sci., 35, 450, 10.1016/j.tibs.2010.03.002 · DOI · Paper page
- Alessi, 1992, The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1, Eur. J. Biochem. FEBS, 210, 1023, 10.1111/j.1432-1033.1992.tb17508.x · DOI · Paper page
- Terry-Lorenzo, 2002, Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton, J. Biol. Chem., 277, 46535, 10.1074/jbc.M206960200 · DOI
- Oliver, 2002, Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology, Mol. Cell. Biol., 22, 4690, 10.1128/MCB.22.13.4690-4701.2002 · DOI
- Ragusa, 2010, Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites, Nat. Struct. Mol. Biol., 17, 459, 10.1038/nsmb.1786 · DOI · Paper page
- Mizutani, 2010, Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function, Circ. J., 74, 120, 10.1253/circj.CJ-09-0462 · DOI
- Yamada, 2006, Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy, FASEB J., 20, 1197, 10.1096/fj.05-5299fje · DOI
- Aoyama, 2011, Isoform-specific roles of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca(2+) cycling, Cardiovasc. Res., 89, 79, 10.1093/cvr/cvq252 · DOI
- Carr, 2002, Type 1 phosphatase, a negative regulator of cardiac function, Mol. Cell. Biol., 22, 4124, 10.1128/MCB.22.12.4124-4135.2002 · DOI · Paper page
- Eschenhagen, 2010, Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?, J. Clin. Invest., 120, 4197, 10.1172/JCI45251 · doi:10.1172/jci45251
- Seguchi, 2007, A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart, J. Clin. Invest., 117, 2812, 10.1172/JCI30804 · DOI · Paper page
- Scruggs, 2010, A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain, Mol. Cell. Proteomics, 9, 1804, 10.1074/mcp.M110.000075 · DOI
- Sanbe, 1999, Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2, J. Biol. Chem., 274, 21085, 10.1074/jbc.274.30.21085 · DOI
- Scruggs, 2009, Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation, J. Biol. Chem., 284, 5097, 10.1074/jbc.M807414200 · DOI
- Karsai, 2013, Cross-species mechanical fingerprinting of cardiac myosin binding protein-C, Biophys. J., 104, 2465, 10.1016/j.bpj.2013.04.027 · DOI
- Sadayappan, 2006, Cardiac myosin binding protein C phosphorylation is cardioprotective, Proc. Natl. Acad. Sci. U. S. A., 103, 16918, 10.1073/pnas.0607069103 · DOI · Paper page
- Solaro, 2013, Integration of troponin I phosphorylation with cardiac regulatory networks, Circ. Res., 112, 355, 10.1161/CIRCRESAHA.112.268672 · DOI
- Metzger, 2004, Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation, Circ. Res., 94, 146, 10.1161/01.RES.0000110083.17024.60 · DOI · Paper page
- Kirchhefer, 2005, Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2, Cardiovasc. Res., 68, 98, 10.1016/j.cardiores.2005.05.019 · DOI
- Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ. Res., 96, 756, 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
- Grote-Wessels, 2008, Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload, Cardiovasc. Res., 79, 464, 10.1093/cvr/cvn113 · DOI
- El-Armouche, 2008, Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy, Cardiovasc. Res., 80, 396, 10.1093/cvr/cvn208 · DOI
- Heijman, 2013, Function and regulation of serine/threonine phosphatases in the healthy and diseased heart, J. Mol. Cell. Cardiol., 64, 90, 10.1016/j.yjmcc.2013.09.006 · DOI
- Sinha, 2013, Selective ablation of Ppp1cc gene in testicular germ cells causes oligo-teratozoospermia and infertility in mice, Biol. Reprod., 89, 128, 10.1095/biolreprod.113.110239 · doi:10.1095/biolreprod.113.110239
- Moses, 2001, Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice, Genesis, 31, 176, 10.1002/gene.10022 · DOI · Paper page
- Sohal, 2001, Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein, Circ. Res., 89, 20, 10.1161/hh1301.092687 · DOI · Paper page
- Kehat, 2011, Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth, Circ. Res., 108, 176, 10.1161/CIRCRESAHA.110.231514 · DOI · Paper page
- Yin, 2010, Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution, Mol. Cell. Proteomics, 9, 497, 10.1074/mcp.M900275-MCP200 · DOI
- Wu, 2009, Plasma membrane Ca2+−ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents, J. Clin. Invest., 119, 976
- Coutu, 2005, Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies, Am. J. Physiol. Heart Circ. Physiol., 288, H613, 10.1152/ajpheart.00425.2004 · DOI
- Davis, 2007, Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+−independent mechanical tone and acute myocyte remodeling, Circ. Res., 100, 1494, 10.1161/01.RES.0000268412.34364.50 · DOI
- Porterfield, 1985, Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements, J. Appl. Physiol., 107, 1693
- Liu, 2009, Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach, Circ. Res., 105, 194, 10.1161/CIRCRESAHA.109.195313 · DOI
- Oka, 2006, Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability, Circ. Res., 98, 837, 10.1161/01.RES.0000215985.18538.c4 · DOI · Paper page
- Maillet, 2010, Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function, J. Biol. Chem., 285, 6716, 10.1074/jbc.M109.056143 · DOI
- Scruggs, 2011, The significance of regulatory light chain phosphorylation in cardiac physiology, Arch. Biochem. Biophys., 510, 129, 10.1016/j.abb.2011.02.013 · DOI
- Satoh, 2006, Requirement of Rac1 in the development of cardiac hypertrophy, Proc. Natl. Acad. Sci. U. S. A., 103, 7432, 10.1073/pnas.0510444103 · DOI · Paper page
- Raake, 2008, G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure, Circ. Res., 103, 413, 10.1161/CIRCRESAHA.107.168336 · DOI
- Burkhoff, 2005, Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers, Am. J. Physiol. Heart Circ. Physiol., 289, H501, 10.1152/ajpheart.00138.2005 · DOI · Paper page
- Nicolaou, 2009, Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology, J. Mol. Cell. Cardiol., 47, 365, 10.1016/j.yjmcc.2009.05.010 · DOI
- Chiang, 2015, Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients, J. Am. Coll. Cardiol., 65, 163, 10.1016/j.jacc.2014.10.042 · DOI
- Miyazaki, 2012, Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling, PLoS ONE, 7, 10.1371/journal.pone.0035875 · DOI
- Sheikh, 2012, Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease, J. Clin. Invest., 122, 1209, 10.1172/JCI61134 · DOI
- Sheikh, 2014, Getting the skinny on thick filament regulation in cardiac muscle biology and disease, Trends Cardiovasc. Med., 24, 133, 10.1016/j.tcm.2013.07.004 · DOI
- Moss, 2015, Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium, Circ. Res., 116, 183, 10.1161/CIRCRESAHA.116.300561 · DOI
- Tong, 2014, Cardiac myosin-binding protein-C is a critical mediator of diastolic function, Pflugers Arch. - Eur. J. Physiol., 466, 451, 10.1007/s00424-014-1442-1 · DOI
- Kotlo, 2012, Phosphoprotein abundance changes in hypertensive cardiac remodeling, J. Proteome, 77, 1, 10.1016/j.jprot.2012.05.041 · DOI
- Yang, 2008, Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ, Biochem. Cell Biol., 86, 70, 10.1139/O07-150 · DOI
- Huang, 2012, Appreciating the strengths and weaknesses of transthoracic echocardiography in hemodynamic assessments, Cardiol. Res. Pract., 894308
- Kirkpatrick, 2007, Echocardiography in heart failure: applications, utility, and new horizons, J. Am. Coll. Cardiol., 50, 381, 10.1016/j.jacc.2007.03.048 · DOI · Paper page
- Nishimura, 2012, Hemodynamics in the cardiac catheterization laboratory of the 21st century, Circulation, 125, 2138, 10.1161/CIRCULATIONAHA.111.060319 · DOI · Paper page
Cited by
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
“For analysis of longitudinal strain and diastolic function by echocardiography, a Vevo 2100 instrument with 18–38 MHz transducer (VisualSonics) was used as previously described (59).”
Self-citationAn acute immune response underlies the benefit of cardiac stem cell therapy
Vagnozzi, R. J., Maillet, M., Sargent, M. A., Khalil, H., Johansen, A. K. Z., Schwanekamp, J. A., York, A. J., Huang, V., Nahrendorf, M., Sadayappan, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1802-2 · Cited by 554
Self-citationThompson, B. R., Soller, K. J., Vetter, A., Yang, J., Veglia, G., Bowser, M. T., & Metzger, J. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.016 · Cited by 2
Metadata
- Authors
- Liu, R., Correll, R. N., Davis, J., Vagnozzi, R. J., York, A. J., Sargent, M. A., Nairn, A. C., & Molkentin, J. D.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 87
- Pages
- 204-213
- ISSN
- 0022-2828
- Cited by
- 50
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.